These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31847229)

  • 1. The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells.
    Lee JH; Mohan CD; Basappa S; Rangappa S; Chinnathambi A; Alahmadi TA; Alharbi SA; Kumar AP; Sethi G; Ahn KS; Rangappa KS
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31847229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor.
    Sanda T; Asamitsu K; Ogura H; Iida S; Utsunomiya A; Ueda R; Okamoto T
    Leukemia; 2006 Apr; 20(4):590-8. PubMed ID: 16453001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.
    Wang CY; Chao TT; Tai WT; Chang FY; Su WP; Chen YL; Chen PT; Weng CY; Yuan A; Shiau CW; Yu CJ; Chen KF
    J Thorac Oncol; 2014 Apr; 9(4):488-96. PubMed ID: 24736071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models.
    Martínez-García D; Pérez-Hernández M; Korrodi-Gregório L; Quesada R; Ramos R; Baixeras N; Pérez-Tomás R; Soto-Cerrato V
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31412593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
    Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
    Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of autophagy by an oleanolic acid derivative, SZC017, promotes ROS-dependent apoptosis through Akt and JAK2/STAT3 signaling pathway in human lung cancer cells.
    Song Y; Kong L; Sun B; Gao L; Chu P; Ahsan A; Qaed E; Lin Y; Peng J; Ma X; Zhang J; Wang S; Tang Z
    Cell Biol Int; 2017 Dec; 41(12):1367-1378. PubMed ID: 28880428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor.
    Sanda T; Iida S; Ogura H; Asamitsu K; Murata T; Bacon KB; Ueda R; Okamoto T
    Clin Cancer Res; 2005 Mar; 11(5):1974-82. PubMed ID: 15756023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.
    Kim BH; Yin CH; Guo Q; Bach EA; Lee H; Sandoval C; Jayabose S; Ulaczyk-Lesanko A; Hall DG; Baeg GH
    Mol Cancer Ther; 2008 Sep; 7(9):2672-80. PubMed ID: 18790749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity
    Son DJ; Zheng J; Jung YY; Hwang CJ; Lee HP; Woo JR; Baek SY; Ham YW; Kang MW; Shong M; Kweon GR; Song MJ; Jung JK; Han SB; Kim BY; Yoon DY; Choi BY; Hong JT
    Theranostics; 2017; 7(18):4632-4642. PubMed ID: 29158850
    [No Abstract]   [Full Text] [Related]  

  • 13. STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma.
    Looyenga BD; Hutchings D; Cherni I; Kingsley C; Weiss GJ; Mackeigan JP
    PLoS One; 2012; 7(2):e30820. PubMed ID: 22319590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of EGFR/STAT3 activity by lupeol contributes to the induction of the apoptosis of human non‑small cell lung cancer cells.
    Min TR; Park HJ; Ha KT; Chi GY; Choi YH; Park SH
    Int J Oncol; 2019 Jul; 55(1):320-330. PubMed ID: 31115519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
    Huang Q; Zhong Y; Li B; Ouyang S; Deng L; Mo J; Shi S; Lv N; Wu R; Liu P; Hu W; Zhang X; Wang Y
    Eur J Med Chem; 2021 Oct; 221():113525. PubMed ID: 34000483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.
    Yang L; Zhou F; Zhuang Y; Liu Y; Xu L; Zhao H; Xiang Y; Dai X; Liu Z; Huang X; Wang L; Zhao C
    Br J Cancer; 2021 Feb; 124(3):645-657. PubMed ID: 33122847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis.
    Mia MM; Bank RA
    J Cell Mol Med; 2015 Dec; 19(12):2780-92. PubMed ID: 26337045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
    Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
    Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.